JANEL (JANL) Director Exercises 2,500 Options at $36.01 on 10/01/2025

John J. Gonzalez II, a director of JANEL CORP (JANL), reported a transaction on Form 4 showing he exercised stock options on 10/01/2025.

Rhea-AI Filing Summary

John J. Gonzalez II, a director of JANEL CORP (JANL), reported a transaction on Form 4 showing he exercised stock options on 10/01/2025. The exercise purchased 2,500 shares of common stock underlying a stock option with an exercise price of $36.01. After the transaction Mr. Gonzalez directly beneficially owns 2,500 shares.

The option's terms show it was exercisable on 12/31/2028 with an expiration date of 09/30/2035, and the reported filing date and signature are 10/03/2025. The Form 4 identifies the filing as by one reporting person and lists Mr. Gonzalez's address in New York, NY.

Positive

• Director exercised options to acquire 2,500 shares, a clear insider purchase disclosure
• Form 4 filed promptly with signature on 10/03/2025, meeting disclosure requirements

Negative

• None.

Insights

Corporate Governance Analyst

Director exercised $36.01 options to acquire 2,500 shares on 10/01/2025.

This Form 4 documents an option exercise by John J. Gonzalez II, who is identified as a director. The filing shows a direct beneficial ownership of 2,500 shares following the exercise, which is a straightforward disclosure of insider activity.

For investors, this is a routine insider report required by Section 16; it discloses timing, quantity, and price but contains no additional commentary or unusual terms.

Insider Trade Summary

Grant/Award: 2,500 shares

Grant/Award 1 txn

Insider Gonzalez John Joseph II

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,500	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,500 contracts (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the JANEL (JANL) Form 4 filed by John J. Gonzalez II disclose?

It discloses an option exercise on 10/01/2025 that acquired 2,500 shares at an exercise price of $36.01.

How many shares does John J. Gonzalez II beneficially own after the transaction?

The Form 4 reports direct beneficial ownership of 2,500 shares following the exercise.

What are the exercise and expiration dates shown on the derivative instrument?

The option lists a date exercisable of 12/31/2028 and an expiration date of 09/30/2035.

When was the Form 4 signed and filed?

The signature line shows the form was signed on 10/03/2025 and the transaction date was 10/01/2025.

What is John J. Gonzalez II's relationship to JANEL CORP?

He is identified on the form as a Director of JANEL CORP.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 01:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Gonzalez John Joseph II

(Last) (First) (Middle)

80 EIGHTH AVENU

(Street)

NEW YORK NY 10011

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JANEL CORP [ JANL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$36.01	10/01/2025		A		2,500		12/31/2028	09/30/2035	Common Stock	2,500	$0	2,500	D

Explanation of Responses:

	/s/ John J. Gonzalez II	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.